Diosmin for healing finger ulcers in scleroderma
Part of Skin clinical trials.
This study tests whether a natural supplement called diosmin can help heal finger and toe ulcers in people with scleroderma. If you have a current ulcer that is not infected, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of systemic sclerosis (scleroderma).
- You have at least one active open sore (digital ulcer) on a finger or toe.
- Your scleroderma medications have been the same for the last 30 days.
- The ulcer is not infected or showing signs of gangrene.
- You are not allergic to citrus fruits (oranges, grapefruits, etc.).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a cell-based treatment (mesenchymal stromal cells) to help heal painful finger/toe ulcers in people with systemic sclerosis. It is for ulcers that did not improve after a specific IV medicine called prostacyclins.
This study looks at hand function and disability in people with systemic sclerosis who have digital ulcers. It aims to understand how these ulcers affect daily hand use.
This Phase 2 study tests whether injections under the skin can help heal painful, poor-circulation (ischemic) finger ulcers caused by scleroderma. It is for people whose ulcers have not improved with usual care.
This study tests a new cream (TOP-N53) for digital ulcers caused by scleroderma. The cream is applied directly to the sore, and the goal is to see if it is safe and helps the ulcer heal.
This trial tests a skin substitute patch that may help diabetic foot ulcers heal faster. It is for people whose ulcer has not improved with standard care and who are willing to follow a strict offloading routine.
This trial tests whether an injected enzyme called hyaluronidase can soften and loosen tight skin on the fingers caused by scleroderma, which may improve flexibility and comfort.
Hear when a new Systemic Scleroderma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.